0002060755-25-000061.txt : 20251201 0002060755-25-000061.hdr.sgml : 20251201 20251201164255 ACCESSION NUMBER: 0002060755-25-000061 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251201 DATE AS OF CHANGE: 20251201 EFFECTIVENESS DATE: 20251201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Algernon Health Inc. CENTRAL INDEX KEY: 0001642178 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565400 FILM NUMBER: 251540233 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 400 - 601 WEST BROADWAY CITY: VANCOUVER PROVINCE COUNTRY: A1 BUSINESS PHONE: 6043984175 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 400 - 601 WEST BROADWAY CITY: VANCOUVER PROVINCE COUNTRY: A1 FORMER COMPANY: FORMER CONFORMED NAME: Algernon Pharmaceuticals Inc. DATE OF NAME CHANGE: 20200527 FORMER COMPANY: FORMER CONFORMED NAME: Breathtec BioMedical, Inc. DATE OF NAME CHANGE: 20161207 FORMER COMPANY: FORMER CONFORMED NAME: Breathtec Biomedical, Inc. DATE OF NAME CHANGE: 20150512 D 1 primary_doc.xml X0708 D LIVE 0001642178 Algernon Health Inc. 400 - 601 WEST BROADWAY VANCOUVER A1 BRITISH COLUMBIA, CANADA V5Z 4C2 6043984175 BRITISH COLUMBIA, CANADA Algernon Pharmaceuticals Inc. Breathtec BioMedical, Inc. Breathtec Biomedical, Inc. Corporation true Christopher Moreau 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Executive Officer Director Chief Executive Officer James Kinley 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Executive Officer Chief Financial Officer Christopher Bryan 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Executive Officer VP, Research & Operations Harry Bloomfield 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Director Raj Attariwala 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Director Howard Gutman 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Director Mark Williams 400 - 601 West Broadway Vancouver A1 BRITISH COLUMBIA, CANADA V5Z 4C2 Director Other Health Care Decline to Disclose 06b false 2025-11-14 true true true true true Units, each consisting of one Class A common share and one-half of one common share purchase warrant, each whole warrant is exercisable to purchase one common share at C$0.15-C$0.50 for a period of 5 years from issuance. false 0 581572 126429 455143 Total Offering Amount = price of Units consisting of Class A common shares (2528572 x $0.05|C$0.07) plus aggregate maximum exercise price of the warrants (1264286 x $0.36|C$0.50). There's no assurance that all warrants will be exercised prior to expiry. false 1 0 0 0 false Algernon Health Inc. /s/ James Kinley James Kinley Chief Financial Officer 2025-12-01